Dirk Eulberg
- Molecular Biology top 5%
- Immunology top 5%
- Epidemiology top 5%
- Hepatology top 1%
- Oncology top 5%
- Co-authors
- Sven KlußmannFrank TackeChristian TrautweinTom LueddeMichael SchlömannHans‐Joachim AndersFelix HeymannChrister Baeck
- Topics
- Chemokine receptors and signaling (10 papers)Cancer Immunotherapy and Biomarkers (7 papers)Immune cells in cancer (6 papers)
- Cited by
- HepatologyNephrologyImmunology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Dirk Eulberg
48 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.5k
- Immunology 880
- Epidemiology 755
- Hepatology 634
- Oncology 497
Countries citing papers authored by Dirk Eulberg
This map shows the geographic impact of Dirk Eulberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Eulberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Eulberg more than expected).
Fields of papers citing papers by Dirk Eulberg
This network shows the impact of papers produced by Dirk Eulberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Eulberg. The network helps show where Dirk Eulberg may publish in the future.
Co-authorship network of co-authors of Dirk Eulberg
This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Eulberg. A scholar is included among the top collaborators of Dirk Eulberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Eulberg. Dirk Eulberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 15 | |
| 3 | 15 | |
| 4 | 86 | |
| 5 | 64 | |
| 6 | 75 | |
| 7 | 1 | |
| 8 | 30 | |
| 9 | 208 | |
| 10 | Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injurybreakdown → | 495 |
| 11 | 94 | |
| 12 | 31 | |
| 13 | 134 | |
| 14 | 38 | |
| 15 | 118 | |
| 16 | 36 | |
| 17 | 145 | |
| 18 | 104 | |
| 19 | 139 | |
| 20 | 28 |
About Dirk Eulberg
Dirk Eulberg is a scholar working on Hepatology, Immunology and Oncology, having authored 49 papers that have together received 3.6k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Hepatology (634 citations), Nephrology (370 citations) and Immunology (880 citations). Dirk Eulberg has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Sven Klußmann, Frank Tacke, Christian Trautwein, Tom Luedde, Michael Schlömann, Hans‐Joachim Anders, Felix Heymann, Christer Baeck, Onkar P. Kulkarni and L. A. Golovleva. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.